Skip to main content
Erschienen in: Obesity Surgery 4/2012

01.04.2012 | Clinical Research

Evolution of Lipid Profiles after Bariatric Surgery

verfasst von: Ignacio Garcia-Marirrodriga, Cesar Amaya-Romero, Gabriel Patiño Ruiz-Diaz, Sandra Férnandez, Carlos Ballesta-López, Jose Ma. Pou, June H. Romeo, Gemma Vilhur, Lina Badimon, Juan Ybarra

Erschienen in: Obesity Surgery | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The most commonly encountered dyslipidemia in obese individuals is characterized by a cluster of interrelated plasma lipid and lipoprotein abnormalities including hypertriglyceridemia, low HDL cholesterol values, and increased small, dense LDL cholesterol particles. The aim of this study was to assess the changes in lipid profiles at baseline (pre-operatively) and at follow-up (6, 12, and 18 months) after a laparoscopic Roux-en-Y gastric bypass (LRYGBP). A retrospective observational study was performed involving all patients who consecutively underwent a LRYGBP between January 1, 2007 and December 31, 2009. Fasting lipids sub-fractions (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) were measured and HOMA-IR calculated pre-operatively and at follow-up post-LRYGBP. Pearson’s correlation coefficients were used to assess the relationship between excess weight loss (EWL) and lipid sub-fractions. ANOVA was used to assess the differences between each lipid sub-fraction at various time-points.

Methods

One hundred twenty eight (N = 128) medical charts were reviewed, and those containing data on lipid fractions at the three follow-up time-points were analyzed. One hundred fourteen patients (N = 114), 84 of whom were women (73.7%), were finally included in the study.

Results

Total cholesterol, LDL cholesterol, triglycerides, and HOMA-IR were significantly reduced after LRYGBP (P < 0.0005 for all). Inversely, HDL cholesterol disclosed a significant rise (P < 0.0005). Noteworthy significant associations between lipid subfractions and EWL were detected overall (P < 0.0005 for all). A gender effect was found since female patients displayed a milder association than male patients (P < 0.0005).

Conclusions

LRYGBP-induced weight loss improves the lipid profile while reducing insulin resistance, with male patients showing a better profile than female patients.
Literatur
1.
Zurück zum Zitat Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–200.PubMedCrossRef Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–200.PubMedCrossRef
2.
Zurück zum Zitat National Institutes of Health Consensus Development Conference. Health implications of obesity. Ann Intern Med. 1985;103:977. National Institutes of Health Consensus Development Conference. Health implications of obesity. Ann Intern Med. 1985;103:977.
3.
Zurück zum Zitat Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13:159–60.PubMedCrossRef Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13:159–60.PubMedCrossRef
4.
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–52.PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–52.PubMedCrossRef
5.
Zurück zum Zitat Donahue RP, Abbott RD, Bloom E, et al. Central obesity and coronary heart disease in men. Lancet. 1987;1:821–4.PubMedCrossRef Donahue RP, Abbott RD, Bloom E, et al. Central obesity and coronary heart disease in men. Lancet. 1987;1:821–4.PubMedCrossRef
6.
Zurück zum Zitat DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94.PubMedCrossRef DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94.PubMedCrossRef
7.
Zurück zum Zitat Bonora E, Zavaroni I, Bruschi F, et al. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab. 1984;59:1121–7.PubMedCrossRef Bonora E, Zavaroni I, Bruschi F, et al. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab. 1984;59:1121–7.PubMedCrossRef
9.
Zurück zum Zitat Sjöström L. Mortality of severely obese subjects. Am J Clin Nutr. 1992;55(Suppl):516S–23S.PubMed Sjöström L. Mortality of severely obese subjects. Am J Clin Nutr. 1992;55(Suppl):516S–23S.PubMed
10.
Zurück zum Zitat Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in White American men. Arch Intern Med. 1993;153:1093–103.PubMedCrossRef Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in White American men. Arch Intern Med. 1993;153:1093–103.PubMedCrossRef
11.
Zurück zum Zitat World Health Organization. Obesity: preventing and managing the global epidemic; report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253. World Health Organization. Obesity: preventing and managing the global epidemic; report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253.
12.
Zurück zum Zitat Després JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497–511.PubMedCrossRef Després JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497–511.PubMedCrossRef
13.
Zurück zum Zitat Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172–9.PubMedCrossRef Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172–9.PubMedCrossRef
14.
Zurück zum Zitat Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002;4:448–53.PubMedCrossRef Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002;4:448–53.PubMedCrossRef
15.
Zurück zum Zitat Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older Black, Mexican–American, and White women and men: an analysis of NHANES III, 1988–1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109–16.PubMedCrossRef Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older Black, Mexican–American, and White women and men: an analysis of NHANES III, 1988–1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109–16.PubMedCrossRef
16.
Zurück zum Zitat Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med. 1998;27:879–90.PubMedCrossRef Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med. 1998;27:879–90.PubMedCrossRef
17.
Zurück zum Zitat Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843–8.PubMedCrossRef Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843–8.PubMedCrossRef
18.
Zurück zum Zitat Shamai L, Lurix E, Shen M, et al. Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obes Surg. 2011;21:42–7.PubMedCrossRef Shamai L, Lurix E, Shen M, et al. Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obes Surg. 2011;21:42–7.PubMedCrossRef
19.
Zurück zum Zitat Sims EA, Danforth Jr E, Horton ES, et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–96.PubMed Sims EA, Danforth Jr E, Horton ES, et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–96.PubMed
20.
Zurück zum Zitat Sharman MJ, Kraemer WJ, Love DM, et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr. 2002;132:1879–85.PubMed Sharman MJ, Kraemer WJ, Love DM, et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr. 2002;132:1879–85.PubMed
21.
Zurück zum Zitat Gower BA, Weinsier RL, Jordan JM, et al. Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and White women. Am J Clin Nutr. 2002;76:923–7.PubMed Gower BA, Weinsier RL, Jordan JM, et al. Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and White women. Am J Clin Nutr. 2002;76:923–7.PubMed
22.
Zurück zum Zitat Huang H, Kasumov T, Gatmaitan P et al (2011) Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) Huang H, Kasumov T, Gatmaitan P et al (2011) Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring)
23.
Zurück zum Zitat Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51(8):2405–12.PubMed Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51(8):2405–12.PubMed
24.
Zurück zum Zitat Broch M, Gómez JM, Auguet MT, et al. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg. 2010;20(9):1258–64.PubMedCrossRef Broch M, Gómez JM, Auguet MT, et al. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg. 2010;20(9):1258–64.PubMedCrossRef
25.
Zurück zum Zitat Pihlajamäki J, Grönlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59(6):866–72.PubMedCrossRef Pihlajamäki J, Grönlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59(6):866–72.PubMedCrossRef
26.
Zurück zum Zitat Johansson HE, Haenni A, Ohrvall M, et al. Alterations in proinsulin and insulin dynamics, HDL cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study. Obes Surg. 2009;19(5):601–7.PubMedCrossRef Johansson HE, Haenni A, Ohrvall M, et al. Alterations in proinsulin and insulin dynamics, HDL cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study. Obes Surg. 2009;19(5):601–7.PubMedCrossRef
27.
Zurück zum Zitat Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg. 2009;19(10):1414–23.PubMedCrossRef Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg. 2009;19(10):1414–23.PubMedCrossRef
28.
Zurück zum Zitat Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45.PubMedCrossRef Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45.PubMedCrossRef
29.
Zurück zum Zitat Ybarra J, Resmini E, Planas F, et al. Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart. Obes Surg. 2009;19:1324–32.PubMedCrossRef Ybarra J, Resmini E, Planas F, et al. Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart. Obes Surg. 2009;19:1324–32.PubMedCrossRef
30.
Zurück zum Zitat Mancia G, de Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.PubMedCrossRef Mancia G, de Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.PubMedCrossRef
31.
Zurück zum Zitat [No authors listed] (1997) American Diabetes Association: clinical practice recommendations 1997. Diabetes Care. 20 (Suppl 1):S1–70 [No authors listed] (1997) American Diabetes Association: clinical practice recommendations 1997. Diabetes Care. 20 (Suppl 1):S1–70
32.
Zurück zum Zitat National Institutes of Health. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference draft statement. Obes Surg. 1991;1:257–66.CrossRef National Institutes of Health. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference draft statement. Obes Surg. 1991;1:257–66.CrossRef
33.
Zurück zum Zitat Alger-Mayer S, Polimeni JM, Malone M. Preoperative weight loss as a predictor of long-term success following Roux-en-Y gastric bypass. Obes Surg. 2008;18(7):772–5.PubMedCrossRef Alger-Mayer S, Polimeni JM, Malone M. Preoperative weight loss as a predictor of long-term success following Roux-en-Y gastric bypass. Obes Surg. 2008;18(7):772–5.PubMedCrossRef
34.
Zurück zum Zitat Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr. 2002;21:365–71.PubMed Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr. 2002;21:365–71.PubMed
35.
Zurück zum Zitat Wittgrove AC, Martinez T. Laparoscopic gastric bypass in patients 60 years and older: early postoperative morbidity and resolution of comorbidities. Obes Surg. 2009;19:1472–6.PubMedCrossRef Wittgrove AC, Martinez T. Laparoscopic gastric bypass in patients 60 years and older: early postoperative morbidity and resolution of comorbidities. Obes Surg. 2009;19:1472–6.PubMedCrossRef
36.
Zurück zum Zitat Ballesta-Lopez C, Poves I, Cabrera M, et al. Learning curve for laparoscopic Roux-en-Y gastric bypass with totally hand-sewn anastomosis: analysis of first 600 consecutive patients. Surg Endosc. 2005;19:519–24.PubMedCrossRef Ballesta-Lopez C, Poves I, Cabrera M, et al. Learning curve for laparoscopic Roux-en-Y gastric bypass with totally hand-sewn anastomosis: analysis of first 600 consecutive patients. Surg Endosc. 2005;19:519–24.PubMedCrossRef
37.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef
38.
Zurück zum Zitat Ybarra J, Pou J, Planas F, et al. Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study. Endocr Pract. 2007;13:590–600.PubMed Ybarra J, Pou J, Planas F, et al. Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study. Endocr Pract. 2007;13:590–600.PubMed
39.
Zurück zum Zitat Bertoni AG, Bonds DE, Steffes S, et al. Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina. Am Heart J. 2006;152(4):785–92.PubMedCrossRef Bertoni AG, Bonds DE, Steffes S, et al. Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina. Am Heart J. 2006;152(4):785–92.PubMedCrossRef
40.
Zurück zum Zitat Ybarra J, Planas F, Navarro-López F, et al. Association between sleep-disordered breathing, aminoterminal pro-brain natriuretic peptide (NT-proBNP) levels and insulin resistance in morbidly obese young women. Eur J Intern Med. 2009;20(2):174–81.PubMedCrossRef Ybarra J, Planas F, Navarro-López F, et al. Association between sleep-disordered breathing, aminoterminal pro-brain natriuretic peptide (NT-proBNP) levels and insulin resistance in morbidly obese young women. Eur J Intern Med. 2009;20(2):174–81.PubMedCrossRef
41.
Zurück zum Zitat Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond). 2010;34(S2):S18–23.CrossRef Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond). 2010;34(S2):S18–23.CrossRef
42.
Zurück zum Zitat Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733–49.PubMedCrossRef Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733–49.PubMedCrossRef
43.
Zurück zum Zitat Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem Biophys Acta. 1994;1215:9–32.PubMed Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem Biophys Acta. 1994;1215:9–32.PubMed
44.
Zurück zum Zitat Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95:158–66.PubMedCrossRef Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95:158–66.PubMedCrossRef
45.
Zurück zum Zitat Burnett JR, Barrett PH, Vicini P, et al. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler Thromb Vasc Biol. 1998;18:1906–14.PubMedCrossRef Burnett JR, Barrett PH, Vicini P, et al. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler Thromb Vasc Biol. 1998;18:1906–14.PubMedCrossRef
46.
Zurück zum Zitat Hamsten A, Silveira A, Boquist S, et al. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol. 2005;45:1013–7.PubMedCrossRef Hamsten A, Silveira A, Boquist S, et al. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol. 2005;45:1013–7.PubMedCrossRef
47.
Zurück zum Zitat McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–9.PubMed McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–9.PubMed
48.
Zurück zum Zitat McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.PubMedCrossRef McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.PubMedCrossRef
49.
Zurück zum Zitat Kolovou GD, Kostakou PM, Anagnostopoulou KK, et al. Therapeutic effects of fibrates in postprandial lipemia. Am J Cardiovasc Drugs. 2008;8:243–55.PubMedCrossRef Kolovou GD, Kostakou PM, Anagnostopoulou KK, et al. Therapeutic effects of fibrates in postprandial lipemia. Am J Cardiovasc Drugs. 2008;8:243–55.PubMedCrossRef
50.
Zurück zum Zitat Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3(1):8–13.PubMedCrossRef Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3(1):8–13.PubMedCrossRef
51.
Zurück zum Zitat Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–43.PubMedCrossRef Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–43.PubMedCrossRef
52.
Zurück zum Zitat Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med. 1999;130(11):933–7.PubMed Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med. 1999;130(11):933–7.PubMed
53.
Zurück zum Zitat Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77.PubMedCrossRef Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77.PubMedCrossRef
54.
Zurück zum Zitat Murphy NF, MacIntyre K, Stewart S, et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15,000 middle aged men and women (the Renfrew–Paisley Study). Eur Heart J. 2006;27:96–106.PubMedCrossRef Murphy NF, MacIntyre K, Stewart S, et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15,000 middle aged men and women (the Renfrew–Paisley Study). Eur Heart J. 2006;27:96–106.PubMedCrossRef
55.
Zurück zum Zitat Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.PubMedCrossRef Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.PubMedCrossRef
56.
Zurück zum Zitat Maher JW, Hawver LM, Pucci A, et al. Four hundred fifty consecutive laparoscopic Roux-en-Y gastric bypasses with no mortality and declining leak rates and lengths of stay in a bariatric training program. J Am Coll Surg. 2008;206:940–4.PubMedCrossRef Maher JW, Hawver LM, Pucci A, et al. Four hundred fifty consecutive laparoscopic Roux-en-Y gastric bypasses with no mortality and declining leak rates and lengths of stay in a bariatric training program. J Am Coll Surg. 2008;206:940–4.PubMedCrossRef
57.
Zurück zum Zitat Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24.PubMedCrossRef Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24.PubMedCrossRef
Metadaten
Titel
Evolution of Lipid Profiles after Bariatric Surgery
verfasst von
Ignacio Garcia-Marirrodriga
Cesar Amaya-Romero
Gabriel Patiño Ruiz-Diaz
Sandra Férnandez
Carlos Ballesta-López
Jose Ma. Pou
June H. Romeo
Gemma Vilhur
Lina Badimon
Juan Ybarra
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 4/2012
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0534-7

Weitere Artikel der Ausgabe 4/2012

Obesity Surgery 4/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.